Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
400,796
-
Share change
-
-14,954
-
Total reported value
-
$729,846
-
Price per share
-
$1.82
-
Number of holders
-
12
-
Value change
-
-$97,971
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q1 2023
As of 31 Mar 2023,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
400,796 shares.
The largest 10 holders included
VANGUARD GROUP INC, UMB Bank, n.a., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Moss Adams Wealth Advisors LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, InterOcean Capital Group, LLC, Ground Swell Capital, LLC, Tower Research Capital LLC (TRC), and UBS Group AG.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.